Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee backs 340B transparency and use rules after marathon debate, with protections for rural providers
Summary
After lengthy testimony and multiple amendments, the committee voted to advance amended Senate Bill 124 (and related provisions) to the Committee of the Whole, adopting reporting and spending-use requirements for 340B net revenue and exemptions for certain small nonprofit hospitals and pharmacies.
The House Health & Human Services Committee advanced a package of measures aimed at increasing transparency and restricting uses of net revenue from the federal 340B Drug Pricing Program, adopting several sponsor amendments after extended testimony from hospitals, rural providers, pharmacies, patients and labor representatives.
Representative Brown and Representative Martinez, co-prime sponsors, framed the effort as an attempt to ensure that 340B savings intended to support low-income and uninsured patients are spent on direct patient services. Brown described key provisions added in committee: an 80% floor requiring that at least 80% of 340B net revenue be used for direct patient services or capital projects that maintain or increase access for low-income populations; exemptions for independent…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
